© CardioDigital Ltd : August 7, 2008
 
 
 

News and Awards


CardioDigital Inc Established in US (March 2007)

The US venture, CardioDigital Inc, has been set up in Portland, Oregon, as the vehicle for the commercialisation of near-to-market technologies developed by the Scottish company. CardioDigital Inc will carry out the final product design and development and market entry, while the UK operation will expand to provide the high-tech engineering skills necessary to bring its range of unique blood pressure and respiratory technologies to market.

CardioDigital Inc is staffed by a number of hand-picked experienced individuals, headed up by Peter Galen, well known in the industry with vast experience both in North America and Asia in getting devices to market. The complimentary skills of the teams on both sides of the Atlantic will ensure success in taking high quality products of significant clinical need to the marketplace.


Blood Pressure Purchase Strengthens CardioDigital's Portfolio (February 2007)

CardioDigital Ltd announced today that it has successfully acquired a technology portfolio relating to continuous non-invasive blood pressure (CNIBP) measurement from Canadian firm VSM MedTech of Vancouver, British Columbia.
For the full press release click here.


CardioDigital receives £0.5M cash injection to revolutionise AF treatment (July 2006)

Atrial Fibrillation (AF) is a heart condition which is highly prevalent in the elderly population causing fatigue, breathlessness and higher risk of stroke. Its management consumes around 1% of the total NHS budget in the UK. The Wellcome Trust, the UK's largest biomedical charity, has awarded £0.5M to CardioDigital Ltd to revolutionise the treatment of this common heart condition.
For the full press release click here.


CD Secures Business Development Funding (April 2006)

CardioDigital has secured further business development funding from the Wellcome Trust, its principle shareholder. This will enable the Company to meet all its strategic business objectives over the coming year.


AF Study Concluded (September 2005)

A feasibility study into the applicability of CardioDigital's technologies to ECGs' from patients presenting with Atrial Fibrillation has been concluded. The results are very encouraging and this exciting new development provides a natural expansion of the Company's current technology portfolio. Full disclosure of the results will be made in the coming months.


Professor David Simpson (August 2005)

Professor David Simpson has been engaged as a consultant to CardioDigital's Board of Directors. From starting Hewlett Packard’s UK business, through his presidency of Gould Inc, to the chairing of 26 new high-tech companies David brings with him a whole spectrum of business experience. For more information click here.


New CEO takes the reigns (June 2005)

As CardioDigital's technologies move towards market readiness former Technical Director Professor Paul Addison has been appointed full time CEO of the company. Former part-time CEO Brendan McGuckin retains his position as Chairman of the Board.


Management Team Expanded (January 2005)

Dr Gordon Forrest has been recruited as a consultant to CardioDigital's Board of Directors. Gordon has a wealth of experience in the medical device sector especially in diagnostics and early stage, high growth companies. For more information click here.


Milestones Achieved (January 2005)

With all technical milestones having been achieved, the third tranche of investment from the Wellcome Trust Technology Transfer Group has been received


PlethRESP™ Demonstration Device (August 2004)

This month saw the completion of a demonstration device incorporating version 1 of CardioDigital's PlethRESP Technology.


COP™ Technology Launch (May 2004)

CardioDigital launches COP technology, a robust tool for the prediction of shock outcome during ventricular fibrillation. 'Utilizing the full power of the unique spectral- temporal analysis offered by the wavelet transform, this tool supersedes the abilities of alternative methods in the market place.' states Professor Paul Addison, Technical Director. See our Research Section for more information on this groundbreaking technology.


Milestones Achieved (January 2004)

With all technical milestones having been achieved, the second tranche of investment from the Wellcome Trust Technology Transfer Group has been received.


New Technologist (July 2003)

A new Research Technologist, Nopadol Uchaipichat, has been appointed. Nopadol graduated with a B.Eng. (Electrical Engineering) from Kasetsart University, Thailand, in 1997. Since then he has undertaken a PhD degree studying the prediction of defibrillation success for patients suffering form ventricular fibrillation. Nopadol has joined the CardioDigital team to apply his skills to the identification of optimal shock timing during the defibrillation process.


Recruitment Continues (May 2003)

CardioDigital have appointed new project co-ordinator. Philippa Boyle will take on the administrative tasks involved in running two large projects as well as general clerical responsibilities within company. Philippa arrives with a wealth of experience in this field as well as a Biology Degree from the Open University.


CardioDigital Relocate to Elvingston (April 2003)

CardioDigital have relocated to Elvingston Science Centre, Scotland. Set in rural East Lothian, yet only a few miles from Edinburgh and its International Airport, this purpose built research facility provides us with idyllic suroundings in which to continue our work. Our new address and phone numbers can be found in the Contact Us section of this web site.


New Technologist Recruited (February 2003)

Dr David Clifton has been appointed to a newly created post of Senior Technologist. Dave joins us after a spell at Napier University where he was investigating the morphology of pulse oximeter traces. He is an electrical engineer by training with particular expertise in signal processing and hardware integration and design.


National Media Interest in £1M Investment (January 2003)

A press release disclosing a total of nearly £1M of investment in CardioDigital has received widespread coverage in both national press (The Sun, Evening News) and TV (STV's Scotland Today). Our Technical Director, Professor Paul Addison, was also in heavy demand making Radio interviews with BBC Scotland and Forth FM.


Catalyst Biomedica invest £600k in CardioDigital (January 2003)

Catalyst Biomedica Ltd - the Venture Capital arm of the Wellcome Trust - have announced a £582k investment in CardioDigital Limited. This funding, along with the Scottish Executive Spur+ Award, will allow the company to expand its portfolio and engage in dedicated research programmes concerned with the development of a number of proprietary technologies for the medical device markets. These include the analysis of ventricular fibrillation, pulse oximetry signals, atrial fibrillation and remotely sensed neonatal heart sounds.


Scottish Executive Grant CD £340k Award (October 2002)

The Scottish Executive have provided a £342k SPUR+ Award for CardioDigital to continue its work developing advanced signal processing algorithms for medical devices. This highly prestigious award is a discretionary grant presented only after a considerable vetting process. The procedures include checks on the soundness of the technology, the IP ownership position, the company's business plan and financial model, and the projected market of the resultant products. Only after all of these factors have been endorsed by third party experts is a grant considered.


Pulse Ox Work Receives Research Prize (Winter 2002)

CardioDigital, along with their clinical collaborators, have won this years EMRS Scholarship Prize for Best Piece of Original Research at the Annual Scientific Meeting of the Faculty of Accident and Emergency Medicine (UK). The award winning work was concerned with the identification of breathing rate from a standard pulse oximeter trace. It is the second time staff from CardioDigital have shared in this Award.


John Logie Baird Award Winners (November 2001)

CardioDigital Directors Paul Addison and Jamie Watson are the winners of this years Edinburgh & Lothian Region John Logie Baird Award For Innovation. Their award was made in the 'Academic and Medical' category for their pioneering work in the analysis of the Pulse Oximetry waveform. Dr Addison collected the award from event organiser Laurence McGarry and CardioDigital went on to represent the Lothian Regions at the National Finals held in Glasgow's National Science Centre.


CONNECT Scotland (September 2001)

After a not-inconsiderable vetting procedure that included interviews and a presentation dry-run CardioDigital was allocated one of the much sought after slots at this years CONNECT conference. Held at the Sheraton Hotel in Edinburgh, this conference provides an opportunity for 'the cream of small businesses in Scotland' to present their case to corporate investors. CEO Brendan McGuckin's presentation was warmly received and generated a great deal of interest. Not least from the BBC, who took up on the public interest angle of improved healthcare in Scotland. CardioDigital featured strongly in BBC Scotland's evening news bulletin which included a brief interview with Dr McGuckin. A more in-depth interview was broadcast on BBC Radio during the Good Morning Scotland business section.

To download the BBC feature Click Here - obtained, with permission, from BBC News Online
(requires an asf movie player such as MS MediaPlayer and is large, 1.7MBytes)


SMART Awards Presentation (June 2001)

The ceremony for the year 2000 SMART Awards was conducted at the Dunblane Hydro Hotel in Scotland. Director Jamie Watson accepted CardioDigital's award from Deputy Minister Alasdair Morrison MSP. The awards received nation press coverage in Scotland and a report can be found on The Herald's internet Business Pages.


Press Release Receives National Coverage (March 2001)

A press release revealing CardioDigital's offical company formation has lead to extensive press coverage in Scotland. Articles are reported in both the national (The Herald) and business (Business AM) press as well as local newspapers (Edinburgh Evening News).


CardioDigital Wins SMART Award (Spring 2000)

A press release from the Scottish Executive confirms that CardioDigital Ltd is one of nine science based companies in Scotland to win a SMART award in the year 2000 round of funding.


Research Award for VF Work (Winter 1999)

The pioneering work by CardioDigital staff and their clinical collaborators revealing hidden structure in the ECG of ventricular fibrillation wins the EMRS Scholarship Prize for Best Piece of Original Research at the Annual Scientific Meeting of the Faculty of Accident and Emergency Medicine (UK).